First Time Loading...
K

Kolon Life Science Inc
KOSDAQ:102940

Watchlist Manager
Kolon Life Science Inc
KOSDAQ:102940
Watchlist
Price: 22 100 KRW -0.23% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

124.6B
-9%
Revenue
Growth Rates:
1 Year
-23%
3 Years
-4%
5 Years
-6%
7 Years
-21%
10 Years
-11%
-24.1B
-23%
Operating Income
Growth Rates:
1 Year
-
3 Years
+7%
5 Years
+30%
7 Years
-
10 Years
-
-30.7B
-72%
Net Income
Growth Rates:
1 Year
-
3 Years
+29%
5 Years
+39%
7 Years
-
10 Years
-

Earnings Waterfall
Kolon Life Science Inc

Revenue
124.6B KRW
Cost of Revenue
-112.2B KRW
Gross Profit
12.4B KRW
Operating Expenses
-36.5B KRW
Operating Income
-24.1B KRW
Other Expenses
-6.6B KRW
Net Income
-30.7B KRW

Income Statement
Kolon Life Science Inc

Rotate your device to view
Income Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
139 611
N/A
135 961
-3%
137 176
+1%
131 195
-4%
130 633
0%
123 871
-5%
121 511
-2%
124 004
+2%
121 175
-2%
125 378
+3%
127 654
+2%
126 590
-1%
158 284
+25%
152 931
-3%
145 842
-5%
146 652
+1%
118 102
-19%
120 060
+2%
128 414
+7%
130 335
+1%
132 680
+2%
136 921
+3%
137 824
+1%
140 251
+2%
148 541
+6%
153 882
+4%
154 163
+0%
159 097
+3%
129 413
-19%
131 508
+2%
134 850
+3%
135 045
+0%
165 485
+23%
162 407
-2%
182 531
+12%
190 606
+4%
161 584
-15%
187 624
+16%
157 220
-16%
137 450
-13%
124 639
-9%
Gross Profit
Cost of Revenue
(96 249)
(95 260)
(97 754)
(96 728)
(97 548)
(94 622)
(95 786)
(98 894)
(95 284)
(95 592)
(94 480)
(89 432)
(109 688)
(105 812)
(101 129)
(104 477)
(89 454)
(94 800)
(104 080)
(108 127)
(121 951)
(126 104)
(126 191)
(126 987)
(122 982)
(122 994)
(120 649)
(119 170)
(110 517)
(112 714)
(114 012)
(116 437)
(128 284)
(129 142)
(146 118)
(155 506)
(124 445)
(151 636)
(132 439)
(118 717)
(112 228)
Gross Profit
43 362
N/A
40 701
-6%
39 422
-3%
34 468
-13%
33 085
-4%
29 249
-12%
25 724
-12%
25 108
-2%
25 891
+3%
29 785
+15%
33 174
+11%
37 158
+12%
48 597
+31%
47 118
-3%
44 712
-5%
42 174
-6%
28 648
-32%
25 260
-12%
24 334
-4%
22 209
-9%
10 729
-52%
10 818
+1%
11 634
+8%
13 264
+14%
25 559
+93%
30 887
+21%
33 514
+9%
39 927
+19%
18 896
-53%
18 794
-1%
20 838
+11%
18 607
-11%
37 202
+100%
33 265
-11%
36 413
+9%
35 100
-4%
37 139
+6%
35 987
-3%
24 781
-31%
18 733
-24%
12 411
-34%
Operating Income
Operating Expenses
(25 023)
(25 629)
(24 965)
(23 638)
(23 690)
(23 578)
(23 855)
(24 380)
(23 709)
(24 451)
(25 166)
(25 890)
(30 137)
(31 709)
(33 019)
(35 077)
(34 193)
(35 000)
(37 661)
(40 694)
(45 290)
(66 085)
(50 164)
(69 427)
(52 439)
(52 565)
(52 597)
(50 092)
(44 732)
(42 214)
(40 575)
(38 241)
(33 328)
(36 888)
(33 583)
(38 167)
(34 497)
(40 063)
(38 202)
(38 325)
(36 506)
Selling, General & Administrative
(14 347)
(14 244)
(13 844)
(13 615)
(13 825)
(14 003)
(14 557)
(17 208)
(14 510)
(13 113)
(15 942)
(16 751)
(18 791)
(31 273)
(29 282)
(27 575)
(19 817)
(23 425)
(24 816)
(26 208)
(23 172)
(25 143)
(24 045)
(24 915)
(31 280)
(30 259)
(33 477)
(32 773)
(28 880)
(25 736)
(22 721)
(21 176)
(18 004)
(17 590)
(17 801)
(18 219)
(19 902)
(21 942)
(21 440)
(20 931)
(20 585)
Research & Development
(10 479)
(10 361)
(10 096)
(9 850)
(9 703)
(9 434)
(9 090)
(6 848)
(8 843)
(10 916)
0
0
(11 035)
0
(3 323)
(7 113)
(13 714)
(10 596)
(11 266)
(12 218)
(19 419)
(20 626)
(22 873)
(23 186)
(18 328)
(18 459)
(15 576)
(14 006)
(13 019)
(13 522)
(13 933)
(13 704)
(14 324)
(13 555)
(14 692)
(14 760)
(13 583)
(14 216)
(12 920)
(13 545)
(14 892)
Depreciation & Amortization
(197)
(184)
(184)
(172)
(162)
(157)
(224)
(340)
(356)
(421)
(381)
(296)
(311)
(277)
(256)
(231)
(662)
(979)
(1 579)
(2 269)
(2 699)
(2 853)
(3 248)
(3 684)
(2 831)
(3 848)
(3 544)
(3 311)
(2 832)
(2 954)
(2 799)
(2 404)
(1 000)
(1 415)
(1 090)
(802)
(1 012)
(1 024)
(1 019)
(1 027)
(1 029)
Other Operating Expenses
0
(840)
(841)
0
0
16
16
16
0
0
(8 843)
(8 843)
0
(159)
(158)
(158)
0
0
0
0
0
(17 463)
0
(17 642)
0
0
0
0
0
0
(1 122)
(957)
0
(4 327)
0
(4 386)
0
(2 881)
(2 822)
(2 822)
0
Operating Income
18 340
N/A
15 071
-18%
14 456
-4%
10 829
-25%
9 395
-13%
5 673
-40%
1 872
-67%
731
-61%
2 183
+199%
5 335
+144%
8 008
+50%
11 268
+41%
18 459
+64%
15 410
-17%
11 693
-24%
7 097
-39%
(5 545)
N/A
(9 742)
-76%
(13 328)
-37%
(18 487)
-39%
(34 561)
-87%
(55 268)
-60%
(38 531)
+30%
(56 164)
-46%
(26 879)
+52%
(21 678)
+19%
(19 083)
+12%
(10 163)
+47%
(25 836)
-154%
(23 418)
+9%
(19 735)
+16%
(19 634)
+1%
3 873
N/A
(3 623)
N/A
2 830
N/A
(3 067)
N/A
2 642
N/A
(4 076)
N/A
(13 421)
-229%
(19 592)
-46%
(24 095)
-23%
Pre-Tax Income
Interest Income Expense
(2 394)
(2 734)
(3 412)
(2 408)
(2 082)
(2 138)
(1 807)
(1 504)
(1 383)
(1 254)
(1 663)
(1 676)
(3 314)
(2 743)
(1 213)
(1 088)
956
888
(178)
(475)
(751)
(1 473)
(14 671)
(15 552)
(15 976)
(16 756)
(5 246)
(5 467)
(5 779)
(5 527)
(4 705)
(4 521)
(5 607)
(5 087)
(4 496)
(3 771)
(3 634)
(4 327)
(5 192)
(6 262)
(6 051)
Non-Reccuring Items
(840)
0
0
(840)
18
0
0
0
0
0
0
0
(158)
0
0
0
0
0
0
0
(17 464)
0
(17 644)
0
(1 875)
(1 932)
(1 801)
(1 965)
(1 191)
(1 169)
0
0
(4 327)
0
(4 386)
0
(2 881)
0
0
0
(3 133)
Gain/Loss on Disposition of Assets
(1 134)
0
(126)
12
(7)
0
(20)
0
(101)
(102)
(105)
0
(594)
(592)
0
0
(14)
0
(152)
(132)
(142)
(146)
38
(10)
(132)
0
(177)
3 432
3 573
3 646
3 655
0
75
(4)
(48)
(53)
(21)
0
(719)
(714)
(7)
Total Other Income
5 844
(228)
(396)
318
(34)
(171)
(89)
(212)
384
539
728
735
495
195
(524)
(699)
222
216
475
526
(1 998)
(42 178)
(43 117)
(43 372)
(35 335)
5 771
5 773
5 197
(13 962)
(14 022)
(11 011)
(10 117)
1 975
2 068
679
1 156
8 018
6 118
6 200
5 956
(312)
Pre-Tax Income
19 816
N/A
12 109
-39%
10 522
-13%
7 912
-25%
7 291
-8%
3 364
-54%
(44)
N/A
(985)
-2 139%
1 083
N/A
4 517
+317%
6 968
+54%
10 327
+48%
14 888
+44%
12 271
-18%
9 956
-19%
5 310
-47%
(4 381)
N/A
(8 638)
-97%
(13 183)
-53%
(18 567)
-41%
(54 917)
-196%
(99 063)
-80%
(113 923)
-15%
(115 096)
-1%
(80 197)
+30%
(34 595)
+57%
(20 535)
+41%
(8 968)
+56%
(43 195)
-382%
(40 490)
+6%
(31 796)
+21%
(34 272)
-8%
(4 011)
+88%
(6 646)
-66%
(5 420)
+18%
(5 734)
-6%
4 124
N/A
(2 285)
N/A
(13 132)
-475%
(20 612)
-57%
(33 598)
-63%
Net Income
Tax Provision
(2 587)
(1 582)
(2 672)
(2 126)
(1 436)
(748)
827
818
(283)
(890)
(1 114)
(1 675)
(2 223)
(1 433)
(734)
604
2 978
4 437
5 196
6 950
4 227
14 072
(7 707)
(10 609)
(12 127)
(23 841)
(3 073)
(2 776)
0
5
2 643
2 645
2 636
2 636
0
0
(108)
(139)
(139)
(139)
(1)
Income from Continuing Operations
17 229
10 527
7 850
5 786
5 855
2 617
784
(165)
800
3 628
5 854
8 651
12 665
10 838
9 223
5 916
(1 404)
(4 201)
(7 986)
(11 617)
(50 690)
(84 990)
(121 631)
(125 705)
(92 323)
(58 435)
(23 605)
(11 743)
(43 195)
(40 485)
(29 154)
(31 627)
(1 375)
(4 011)
(5 420)
(5 734)
4 016
(2 424)
(13 272)
(20 751)
(33 599)
Net Income (Common)
17 229
N/A
10 527
-39%
7 850
-25%
5 786
-26%
5 855
+1%
2 617
-55%
784
-70%
(165)
N/A
800
N/A
3 628
+354%
5 854
+61%
8 651
+48%
12 665
+46%
10 838
-14%
9 223
-15%
5 916
-36%
(1 404)
N/A
(4 201)
-199%
(7 986)
-90%
(11 617)
-45%
(50 690)
-336%
(84 990)
-68%
(121 631)
-43%
(125 705)
-3%
(92 323)
+27%
(58 435)
+37%
(23 605)
+60%
(11 743)
+50%
(43 195)
-268%
(40 485)
+6%
(29 154)
+28%
(31 627)
-8%
(1 375)
+96%
(4 011)
-192%
(5 420)
-35%
(5 734)
-6%
2 133
N/A
334
-84%
(10 346)
N/A
(17 825)
-72%
(30 726)
-72%
EPS (Diluted)
1 722.9
N/A
1 052.7
-39%
785
-25%
578.6
-26%
585.5
+1%
261.7
-55%
78.4
-70%
-16.5
N/A
80
N/A
362.8
+354%
585.4
+61%
786.45
+34%
1 151.36
+46%
985.27
-14%
838.45
-15%
537.81
-36%
-127.63
N/A
-381.9
-199%
-726
-90%
-1 056.09
-45%
-4 608.18
-336%
-7 726.36
-68%
-11 057.36
-43%
-11 427.72
-3%
-8 393
+27%
-5 312.27
+37%
-2 145.9
+60%
-1 067.54
+50%
-3 926.81
-268%
-3 680.45
+6%
-2 557.33
+31%
-2 774.24
-8%
-120.61
+96%
-351.81
-192%
-474.87
-35%
-457.07
+4%
153
N/A
29.25
-81%
-906.54
N/A
-1 561.91
-72%
-2 692.37
-72%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.